S.M. Ess

6.8k total citations
42 papers, 1.4k citations indexed

About

S.M. Ess is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, S.M. Ess has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Pathology and Forensic Medicine. Recurrent topics in S.M. Ess's work include Global Cancer Incidence and Screening (15 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Risks and Factors (7 papers). S.M. Ess is often cited by papers focused on Global Cancer Incidence and Screening (15 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Risks and Factors (7 papers). S.M. Ess collaborates with scholars based in Switzerland, United States and Italy. S.M. Ess's co-authors include Thomas D. Szucs, Sebastian Schneeweiß, Gernot Jundt, Penelope Vounatsou, Thomas Cerny, Gary M. Clifford, Silvia Franceschi, Christine Bouchardy, Andrea Bordoni and Matthias Cavassini and has published in prestigious journals such as Blood, Clinical Infectious Diseases and American Journal of Epidemiology.

In The Last Decade

S.M. Ess

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.M. Ess Switzerland 18 731 362 266 217 206 42 1.4k
Katherine Van Loon United States 21 956 1.3× 256 0.7× 213 0.8× 68 0.3× 270 1.3× 126 1.7k
Arduino Verdecchia Italy 12 636 0.9× 167 0.5× 172 0.6× 115 0.5× 179 0.9× 17 1.2k
Daniela Cristina Stefan South Africa 25 704 1.0× 279 0.8× 267 1.0× 100 0.5× 164 0.8× 91 1.8k
Aurélien Belot France 31 1.4k 1.9× 489 1.4× 483 1.8× 365 1.7× 513 2.5× 107 3.0k
Marek S. Poniewierski United States 18 1.3k 1.7× 171 0.5× 146 0.5× 115 0.5× 128 0.6× 64 1.7k
Mark Liebow United States 23 229 0.3× 172 0.5× 225 0.8× 216 1.0× 149 0.7× 44 1.5k
Thomas E. Delea United States 26 763 1.0× 131 0.4× 61 0.2× 378 1.7× 304 1.5× 136 2.4k
Deborah Jaffe United States 6 415 0.6× 397 1.1× 43 0.2× 148 0.7× 98 0.5× 6 1.0k
Eva Segelov Australia 25 1.4k 2.0× 526 1.5× 253 1.0× 91 0.4× 417 2.0× 158 2.4k
J W Horm United States 10 730 1.0× 227 0.6× 195 0.7× 103 0.5× 114 0.6× 14 1.3k

Countries citing papers authored by S.M. Ess

Since Specialization
Citations

This map shows the geographic impact of S.M. Ess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.M. Ess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.M. Ess more than expected).

Fields of papers citing papers by S.M. Ess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.M. Ess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.M. Ess. The network helps show where S.M. Ess may publish in the future.

Co-authorship network of co-authors of S.M. Ess

This figure shows the co-authorship network connecting the top 25 collaborators of S.M. Ess. A scholar is included among the top collaborators of S.M. Ess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.M. Ess. S.M. Ess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ess, S.M., C. Herrmann, Christine Bouchardy, et al.. (2018). Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies. The Breast. 41. 151–158. 14 indexed citations
2.
Herrmann, C., Penelope Vounatsou, Beat Thürlimann, et al.. (2018). Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies. BMJ Open. 8(3). e017806–e017806. 18 indexed citations
3.
Güller, Ulrich, René Warschkow, Christoph Ackermann, et al.. (2017). Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection. Swiss Medical Weekly. 147(2930). w14473–w14473. 30 indexed citations
5.
Putora, Paul Martin, S.M. Ess, Cédric Panje, et al.. (2015). Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC). Clinical & Experimental Metastasis. 32(2). 143–149. 16 indexed citations
6.
Bodmer, Alexandre, Anita Feller, Andrea Bordoni, et al.. (2014). Breast cancer in younger women in Switzerland 1996–2009: A longitudinal population-based study. The Breast. 24(2). 112–117. 19 indexed citations
7.
Ess, S.M., Harish C. Phuleria, Martin Früh, et al.. (2013). Tobacco-related cancer mortality: projections for different geographical regions in Switzerland. Swiss Medical Weekly. 143(2324). w13771–w13771. 3 indexed citations
8.
Herrmann, C., Thomas Cerny, Penelope Vounatsou, et al.. (2013). Cancer survivors in Switzerland: a rapidly growing population to care for. BMC Cancer. 13(1). 287–287. 26 indexed citations
9.
Ess, S.M., Harish C. Phuleria, Martin Früh, et al.. (2013). Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland. Geospatial health. 7(2). 219–219. 8 indexed citations
10.
Clifford, Gary M., M. Lise, Silvia Franceschi, et al.. (2012). Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. British Journal of Cancer. 106(3). 447–452. 58 indexed citations
11.
Joerger, Markus, Beat Thürlimann, Harald Frick, et al.. (2011). A Population-Based Study on the Implementation of Treatment Recommendations for Chemotherapy in Early Breast Cancer. Clinical Breast Cancer. 12(2). 102–109. 6 indexed citations
12.
Franceschi, Silvia, M. Lise, Gary M. Clifford, et al.. (2010). Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. British Journal of Cancer. 103(3). 416–422. 221 indexed citations
13.
Ess, S.M., et al.. (2010). Premature deaths in Switzerland from 1995–2006: causes and trends. Swiss Medical Weekly. 140(3334). w13077–w13077. 17 indexed citations
14.
Ess, S.M., Markus Joerger, H. Frick, et al.. (2010). Predictors of state-of-the-art management of early breast cancer in Switzerland. Annals of Oncology. 22(3). 618–624. 13 indexed citations
15.
Clifford, Gary M., Martin Rickenbach, M. Lise, et al.. (2009). Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood. 113(23). 5737–5742. 76 indexed citations
17.
Déglise, Carole, Christine Bouchardy, Mafalda Burri, et al.. (2009). Impact of obesity on diagnosis and treatment of breast cancer. Breast Cancer Research and Treatment. 120(1). 185–193. 49 indexed citations
18.
Franceschi, Silvia, Luigino Dal Maso, Martin Rickenbach, et al.. (2008). Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. British Journal of Cancer. 99(5). 800–804. 112 indexed citations
19.
Ess, S.M., et al.. (2003). Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland. Vaccine. 21(23). 3273–3281. 45 indexed citations
20.
Ess, S.M., Thomas F. Lüscher, & Thomas D. Szucs. (2002). High Dose Lisinopril in Heart Failure: Economic Considerations. Cardiovascular Drugs and Therapy. 16(4). 365–371. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026